About this trial
The Johns Hopkins Pediatric Radiation Oncology Program is creating a registry that will capture the full 3D radiation dosimetry delivered to its pediatric patients to manage the quality of care provided, as well as to examine the long-term outcomes and toxicity of each patient. The registry will capture baseline clinical data, disease, toxicity, and quality of life outcomes. The goal is to include all pediatric patients undergoing proton therapy and photon therapy to enable future comparisons of treatment outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Treatment with either proton or photon radiation therapy.
Disqualifiers
Greater than 26 years old
Trial population
Pediatric brain tumor and bone and soft tissue sarcoma patients that are being treated with proton or photon radiation therapy.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Overall Survival
Measured from date of diagnosis until death, obtained from medical record notes
Toxicity due to Radiation Therapy as assessed by number of patients with adverse events
The number of patients that experience adverse events, obtained from medical record notes
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead sponsor
Clark Charitable Foundation Inc.
Collaborator